| Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, ... JAMA internal medicine 181 (1), 24-31, 2021 | 783 | 2021 |
| Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge M Bellan, D Soddu, PE Balbo, A Baricich, P Zeppegno, GC Avanzi, ... JAMA network open 4 (1), e2036142-e2036142, 2021 | 521 | 2021 |
| Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor PP Sainaghi, L Castello, L Bergamasco, M Galletti, P Bellosta, GC Avanzi Journal of cellular physiology 204 (1), 36-44, 2005 | 267 | 2005 |
| Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open … F Humby, P Durez, MH Buch, MJ Lewis, H Rizvi, F Rivellese, A Nerviani, ... The Lancet 397 (10271), 305-317, 2021 | 255 | 2021 |
| The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance GP Carnevale Schianca, A Rossi, PP Sainaghi, E Maduli, E Bartoli Diabetes care 26 (5), 1333-1337, 2003 | 248 | 2003 |
| Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to SARS-CoV-2 E Barberis, S Timo, E Amede, VV Vanella, C Puricelli, G Cappellano, ... International journal of molecular sciences 21 (22), 8623, 2020 | 228 | 2020 |
| TNF-α, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages F Alciato, PP Sainaghi, D Sola, L Castello, GC Avanzi Journal of leukocyte biology 87 (5), 869-875, 2010 | 228 | 2010 |
| Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ... Journal of clinical medicine 8 (11), 2013, 2019 | 190 | 2019 |
| Circulating exosomes are strongly involved in SARS-CoV-2 infection E Barberis, VV Vanella, M Falasca, V Caneapero, G Cappellano, ... Frontiers in molecular biosciences 8, 632290, 2021 | 187 | 2021 |
| Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ... Journal of translational medicine 18 (1), 405, 2020 | 156 | 2020 |
| Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients M Bellan, G Patti, E Hayden, D Azzolina, M Pirisi, A Acquaviva, ... Scientific reports 10 (1), 20731, 2020 | 145 | 2020 |
| Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 M Bellan, A Baricich, F Patrucco, P Zeppegno, C Gramaglia, PE Balbo, ... Scientific reports 11 (1), 22666, 2021 | 144 | 2021 |
| Circulating platelet-derived extracellular vesicles are a hallmark of Sars-Cov-2 infection G Cappellano, D Raineri, R Rolla, M Giordano, C Puricelli, B Vilardo, ... Cells 10 (1), 85, 2021 | 109 | 2021 |
| RCT-TCZ-COVID-19 Study Group. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, ... JAMA Intern Med 181 (1), 24-31, 2021 | 94 | 2021 |
| Comorbidities, cardiovascular therapies, and COVID-19 mortality: a nationwide, Italian observational study (ItaliCO) F Polverino, DA Stern, G Ruocco, E Balestro, M Bassetti, M Candelli, ... Frontiers in cardiovascular medicine 7, 585866, 2020 | 87 | 2020 |
| Pathophysiological role and therapeutic implications of vitamin D in autoimmunity: focus on chronic autoimmune diseases M Bellan, L Andreoli, C Mele, PP Sainaghi, C Rigamonti, S Piantoni, ... Nutrients 12 (3), 789, 2020 | 85 | 2020 |
| The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain–Barré syndrome from chronic inflammatory demyelinating polyneuropathy PP Sainaghi, L Collimedaglia, F Alciato, MA Leone, P Naldi, R Molinari, ... Cytokine 51 (2), 138-143, 2010 | 81 | 2010 |
| Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe DJ Pinato, AJX Lee, F Biello, E Segui, J Aguilar-Company, A Carbo, ... Cancers 12 (7), 1841, 2020 | 80 | 2020 |
| “War to the knife” against thromboinflammation to protect endothelial function of COVID-19 patients G Guglielmetti, M Quaglia, PP Sainaghi, LM Castello, R Vaschetto, ... Critical Care 24 (1), 365, 2020 | 69 | 2020 |
| Gas6/TAM system: a key modulator of the interplay between inflammation and fibrosis M Bellan, MG Cittone, S Tonello, C Rigamonti, LM Castello, F Gavelli, ... International journal of molecular sciences 20 (20), 5070, 2019 | 60 | 2019 |
